Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Inhaled Ambisome in Lung Transplant Recipients
NCT00177710Phase 3Completed
- Sponsor
- University of Pittsburgh
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of amphotericin b in fungal infection, sponsored by University of Pittsburgh. Primary endpoints: Pharmacokinetic profile of liposomal amphotericin B in serum at 168 hours and Pharmacokinetic profile of liposomal amphotericin B in epithelial lining fluid at 168 hours. Started Jan 2006; status: completed.
02
Drugs
amphotericin b
03
Conditions
fungal infection
Beyond the preview
Go deeper on NCT00177710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00177710.